Thursday, August 6, 2026

HomeBusiness NewsAusCann looking to trial cannabinoid treatment for spinal cord injuries

AusCann looking to trial cannabinoid treatment for spinal cord injuries

- Advertisement -

Australian medicinal cannabis company AusCann (ASX: AC8) today announced it is preparing a trial of its proprietary cannabinoid-based formulations in people with spinal cord injury (SCI).

The company, which acquired CannPal Animal Therapeutics for $17.5 million earlier this year, has commenced…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed